West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 580,200 | 548,000 | 527,200 | 491,500 | 470,600 |
| Cost of Goods | 369,100 | 353,400 | 332,100 | 324,500 | 317,400 |
| Gross Profit | 211,100 | 194,600 | 195,100 | 167,000 | 153,200 |
| Operating Expenses | 95,100 | 95,800 | 91,600 | 79,500 | 75,500 |
| Operating Income | 116,100 | 99,200 | 103,600 | 88,000 | 78,100 |
| Interest Expense | 2,100 | 2,100 | 2,000 | 2,000 | 2,100 |
| Other Income | 4,800 | 6,300 | 5,600 | 3,300 | 4,400 |
| Pre-tax Income | 118,800 | 103,400 | 107,200 | 89,300 | 80,400 |
| Income Tax | 20,400 | 21,100 | 16,000 | 15,000 | 16,500 |
| Net Income Continuous | 98,400 | 82,300 | 91,200 | 74,300 | 63,900 |
| Net Income | $98,400 | $82,300 | $91,200 | $74,300 | $63,900 |
| EPS Basic Total Ops | 1.32 | 1.11 | 1.24 | 1.01 | 0.86 |
| EPS Basic Continuous Ops | 1.33 | 1.11 | 1.24 | 1.01 | 0.86 |
| EPS Diluted Total Ops | 1.28 | 1.09 | 1.21 | 0.99 | 0.85 |
| EPS Diluted Continuous Ops | 1.29 | 1.09 | 1.21 | 0.98 | 0.84 |
| EBITDA(a) | $144,600 | $127,600 | $129,800 | $114,000 | $104,400 |